+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopharmaceutical Third Party Logistics Market by Service Type, Temperature Range, Mode Of Transportation, End User, Product Type, Packaging Type - Global Forecast 2025-2030- Product Image
Biopharmaceutical Third Party Logistics Market by Service Type, Temperature Range, Mode Of Transportation, End User, Product Type, Packaging Type - Global Forecast 2025-2030- Product Image
Sale

Biopharmaceutical Third Party Logistics Market by Service Type, Temperature Range, Mode Of Transportation, End User, Product Type, Packaging Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010883
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biopharmaceutical third-party logistics market is evolving rapidly as supply chains adapt to the specialized requirements of advanced therapies. Providers are responding with integrated, technology-driven solutions to ensure product integrity, compliance, and efficiency as global demand intensifies.

Market Snapshot: Biopharmaceutical Third Party Logistics Market

The Biopharmaceutical Third Party Logistics Market grew from USD 121.77 billion in 2024 to USD 140.03 billion in 2025. It is expected to continue growing at a CAGR of 14.31%, reaching USD 271.72 billion by 2030. This sustained performance underscores escalating pressures from increasingly complex biopharma pipelines, stringent regulatory requirements, and globalization of drug development and delivery. Expanding demand for temperature-controlled logistics is matched by rising expectations for operational transparency, risk mitigation, and tailored regional service strategies.

Scope & Segmentation

  • Service Types: Distribution management, packaging and labeling (active and passive solutions including controlled atmosphere packaging and refrigerated containers), transportation (express and standard air, rail, road, sea), warehousing (ambient and cold storage).
  • Temperature Ranges: Ambient, chilled (monitored and standard), controlled room temperature (monitored and standard), frozen (standard and ultra-frozen).
  • Modes of Transportation: Air freight (express and standard), rail, road (full and less-than-truck load), sea (full and less-than-container load).
  • End Users: Biopharmaceutical manufacturers, contract manufacturing organizations, contract research organizations, diagnostic laboratories, hospitals and clinics (community and research hospitals).
  • Product Types: Cell therapies (dendritic and stem cell), gene therapies, monoclonal antibodies, recombinant proteins, vaccines (inactivated, live attenuated).
  • Packaging Types: Active packaging (refrigerated containers, temperature-controlled shippers), passive packaging (insulated boxes, thermal blankets).
  • Geographies: Americas, Europe, Middle East & Africa, Asia-Pacific, with key representation from markets such as the United States, Canada, China, India, Germany, and others.
  • Technologies: IoT-enabled monitoring, real-time shipment tracking, predictive analytics, robotic process automation, cold storage innovation.

Key Takeaways for Senior Decision-Makers

  • Growing demand for personalized and high-value therapies is intensifying requirements across the entire biopharmaceutical logistics chain, with specialized solutions for cell and gene treatments.
  • Technology adoption—such as IoT sensors and digital control towers—is transforming supply chain visibility, streamlining temperature management and compliance.
  • Regional strategies must account for infrastructure variability, regulatory diversity, and emerging local manufacturing capabilities, affecting expansion and risk profiles.
  • Strategic partnerships—between logistics specialists, contract organizations, and manufacturers—are driving vertically integrated supply chains that enhance reliability and reduce product handling risks.
  • Packaging innovation, like temperature-controlled shippers and phase change materials, is crucial to safeguard product quality along increasingly complex routes.
  • Operational resilience increasingly depends on workforce expertise and continuous training in regulatory standards, data analysis, and advanced logistics processes.

Tariff Impact on Biopharmaceutical Logistics Planning

Recent United States tariff adjustments have reshaped logistics planning by increasing costs for raw materials, consumables, and specialized equipment. Service providers are responding with nearshoring, supplier diversification, and multimodal transportation strategies to balance speed and cost. Collaborative scenario planning and data-driven procurement are helping mitigate the impact across pharma supply networks and maintain product affordability.

Methodology & Data Sources

This report integrates structured interviews with industry executives, up-to-date regulatory content, and quantitative analysis of trade statistics. Advanced statistical models, peer review by supply chain experts, and a multi-layered segmentation framework ensure credibility and actionable insight.

Why This Report Matters

  • Enables informed decision-making by providing comprehensive market intelligence across service models, technology adoption, and regulatory trends.
  • Supplies actionable insights for optimizing operational efficiency, compliance, and long-term competitive positioning within the biopharmaceutical logistics sector.
  • Supports strategy development for regional expansion and risk management in a dynamic, compliance-driven environment.

Conclusion

The biopharmaceutical third-party logistics market is entering a period of sustainable transformation, shaped by increasing service complexity and relentless innovation. Companies equipped with technology-enabled, flexible strategies will be best positioned for future growth and resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of AI-driven real-time temperature monitoring solutions to ensure biologic stability during cold chain logistics
5.2. Expansion of specialized GDP-compliant facilities to support cell and gene therapy storage and distribution requirements
5.3. Implementation of digital twin technology for predictive modeling of complex biopharma supply chain disruptions
5.4. Collaboration between 3PL providers and regulatory bodies to streamline serialization and track-and-trace compliance
5.5. Development of multi-modal transportation networks integrating air, sea, and ground to optimize cold chain efficiency globally
5.6. Investment in sustainable cold chain packaging solutions to reduce carbon footprint and maintain product integrity over long distances
5.7. Adoption of blockchain-enabled platforms for enhanced transparency in biologics provenance and temperature excursion tracking
5.8. Rising demand for end-to-end visibility platforms integrating IoT sensors and cloud analytics in temperature-sensitive shipments
5.9. Strategic partnerships for last-mile delivery customized to hospital and clinical trial requirements in mRNA vaccine distribution
5.10. Growth of on-demand warehousing models offering scalable capacity and flexible lease terms for biopharma distribution networks
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biopharmaceutical Third Party Logistics Market, by Service Type
8.1. Introduction
8.2. Distribution Management
8.3. Packaging & Labeling
8.3.1. Active Packaging
8.3.1.1. Controlled Atmosphere Packaging
8.3.1.2. Refrigerated Containers
8.3.2. Labeling Services
8.3.3. Passive Packaging
8.4. Transportation
8.4.1. Air Transport
8.4.1.1. Express Air
8.4.1.2. Standard Air
8.4.2. Rail Transport
8.4.3. Road Transport
8.4.4. Sea Transport
8.5. Warehousing
8.5.1. Ambient Storage Warehousing
8.5.2. Cold Storage Warehousing
9. Biopharmaceutical Third Party Logistics Market, by Temperature Range
9.1. Introduction
9.2. Ambient
9.3. Chilled
9.3.1. Monitored Chilled
9.3.2. Standard Chilled
9.4. Controlled Room Temperature
9.4.1. Monitored Controlled Room Temperature
9.4.2. Standard Controlled Room Temperature
9.5. Frozen
9.5.1. Standard Frozen
9.5.2. Ultra Frozen
10. Biopharmaceutical Third Party Logistics Market, by Mode Of Transportation
10.1. Introduction
10.2. Air Freight
10.2.1. Express Air
10.2.2. Standard Air
10.3. Rail Freight
10.4. Road Transport
10.4.1. Full Truck Load
10.4.2. Less Than Truck Load
10.5. Sea Freight
10.5.1. Full Container Load
10.5.2. Less Than Container Load
11. Biopharmaceutical Third Party Logistics Market, by End User
11.1. Introduction
11.2. Biopharmaceutical Manufacturers
11.3. Contract Manufacturing Organizations
11.4. Contract Research Organizations
11.5. Diagnostic Laboratories
11.6. Hospitals & Clinics
11.6.1. Community Hospitals
11.6.2. Research Hospitals
12. Biopharmaceutical Third Party Logistics Market, by Product Type
12.1. Introduction
12.2. Cell Therapies
12.2.1. Dendritic Cell Therapies
12.2.2. Stem Cell Therapies
12.3. Gene Therapies
12.4. Monoclonal Antibodies
12.5. Recombinant Proteins
12.6. Vaccines
12.6.1. Inactivated
12.6.2. Live Attenuated
13. Biopharmaceutical Third Party Logistics Market, by Packaging Type
13.1. Introduction
13.2. Active Packaging
13.2.1. Refrigerated Containers
13.2.2. Temperature Controlled Shippers
13.3. Passive Packaging
13.3.1. Insulated Boxes
13.3.2. Thermal Blankets
14. Americas Biopharmaceutical Third Party Logistics Market
14.1. Introduction
14.2. Canada
14.3. Argentina
14.4. United States
14.5. Mexico
14.6. Brazil
15. Europe, Middle East & Africa Biopharmaceutical Third Party Logistics Market
15.1. Introduction
15.2. Finland
15.3. Russia
15.4. Egypt
15.5. Saudi Arabia
15.6. Switzerland
15.7. Italy
15.8. South Africa
15.9. Norway
15.10. Poland
15.11. Nigeria
15.12. Qatar
15.13. Sweden
15.14. Spain
15.15. Germany
15.16. Israel
15.17. France
15.18. United Kingdom
15.19. Denmark
15.20. United Arab Emirates
15.21. Netherlands
15.22. Turkey
16. Asia-Pacific Biopharmaceutical Third Party Logistics Market
16.1. Introduction
16.2. Vietnam
16.3. Japan
16.4. India
16.5. Australia
16.6. Indonesia
16.7. China
16.8. Singapore
16.9. Philippines
16.10. South Korea
16.11. Thailand
16.12. Malaysia
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Kuehne + Nagel International AG
17.3.2. Deutsche Post AG
17.3.3. DSV Panalpina A/S
17.3.4. DB Schenker Logistics Germany AG & Co. KG
17.3.5. United Parcel Service, Inc.
17.3.6. FedEx Corporation
17.3.7. CEVA Logistics AG
17.3.8. Agility Public Warehousing Company K.S.C.P.
17.3.9. Bolloré SE
17.3.10. Expeditors International of Washington, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET: RESEARCHAI
FIGURE 28. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET: RESEARCHSTATISTICS
FIGURE 29. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET: RESEARCHCONTACTS
FIGURE 30. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DISTRIBUTION MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DISTRIBUTION MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ATMOSPHERE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ATMOSPHERE PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REFRIGERATED CONTAINERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REFRIGERATED CONTAINERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LABELING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LABELING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY EXPRESS AIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY EXPRESS AIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD AIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD AIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RAIL TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RAIL TRANSPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA TRANSPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AMBIENT STORAGE WAREHOUSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AMBIENT STORAGE WAREHOUSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COLD STORAGE WAREHOUSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COLD STORAGE WAREHOUSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AMBIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AMBIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONITORED CHILLED, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONITORED CHILLED, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD CHILLED, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD CHILLED, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONITORED CONTROLLED ROOM TEMPERATURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONITORED CONTROLLED ROOM TEMPERATURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD CONTROLLED ROOM TEMPERATURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD CONTROLLED ROOM TEMPERATURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD FROZEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD FROZEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ULTRA FROZEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ULTRA FROZEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY EXPRESS AIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY EXPRESS AIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD AIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STANDARD AIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RAIL FREIGHT, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RAIL FREIGHT, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FULL TRUCK LOAD, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FULL TRUCK LOAD, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LESS THAN TRUCK LOAD, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LESS THAN TRUCK LOAD, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FULL CONTAINER LOAD, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FULL CONTAINER LOAD, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LESS THAN CONTAINER LOAD, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LESS THAN CONTAINER LOAD, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RESEARCH HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RESEARCH HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DENDRITIC CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY DENDRITIC CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY GENE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY GENE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REFRIGERATED CONTAINERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REFRIGERATED CONTAINERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED SHIPPERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED SHIPPERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY INSULATED BOXES, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY INSULATED BOXES, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY THERMAL BLANKETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY THERMAL BLANKETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 217. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 218. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 219. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, 2018-2024 (USD MILLION)
TABLE 220. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, 2025-2030 (USD MILLION)
TABLE 221. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 222. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 223. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2024 (USD MILLION)
TABLE 224. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2025-2030 (USD MILLION)
TABLE 225. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, 2018-2024 (USD MILLION)
TABLE 226. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, 2025-2030 (USD MILLION)
TABLE 227. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, 2018-2024 (USD MILLION)
TABLE 228. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, 2025-2030 (USD MILLION)
TABLE 229. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2024 (USD MILLION)
TABLE 230. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2025-2030 (USD MILLION)
TABLE 231. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, 2018-2024 (USD MILLION)
TABLE 232. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CHILLED, 2025-2030 (USD MILLION)
TABLE 233. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, 2018-2024 (USD MILLION)
TABLE 234. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, 2025-2030 (USD MILLION)
TABLE 235. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, 2018-2024 (USD MILLION)
TABLE 236. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY FROZEN, 2025-2030 (USD MILLION)
TABLE 237. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2024 (USD MILLION)
TABLE 238. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY MODE OF TRANSPORTATION, 2025-2030 (USD MILLION)
TABLE 239. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2024 (USD MILLION)
TABLE 240. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2025-2030 (USD MILLION)
TABLE 241. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, 2018-2024 (USD MILLION)
TABLE 242. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ROAD TRANSPORT, 2025-2030 (USD MILLION)
TABLE 243. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2024 (USD MILLION)
TABLE 244. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2025-2030 (USD MILLION)
TABLE 245. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 248. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 249. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 252. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 253. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 254. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 255. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
TABLE 256. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING TYPE, 2025-2030 (USD MILLION)
TABLE 257. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 258. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 259. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 260. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PASSIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY PACKAGING & LABELING, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY ACTIVE PACKAGING, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR TRANSPORT, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2024 (USD M

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biopharmaceutical Third Party Logistics market report include:
  • Kuehne + Nagel International AG
  • Deutsche Post AG
  • DSV Panalpina A/S
  • DB Schenker Logistics Germany AG & Co. KG
  • United Parcel Service, Inc.
  • FedEx Corporation
  • CEVA Logistics AG
  • Agility Public Warehousing Company K.S.C.P.
  • Bolloré SE
  • Expeditors International of Washington, Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 140.03 Billion
Forecasted Market Value ( USD ) by 2030 $ 271.72 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain Logistics, Non-cold Chain Logistics), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain Logistics, Non-cold Chain Logistics), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 160 Pages
  • Global
From
Healthcare Cold Chain Third Party Logistics Market Size, Share & Trends Analysis Report by Service (Warehousing & Storage, Packaging Solutions), Product (Biopharmaceuticals), Temperature Range, End Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Healthcare Cold Chain Third Party Logistics Market Size, Share & Trends Analysis Report by Service (Warehousing & Storage, Packaging Solutions), Product (Biopharmaceuticals), Temperature Range, End Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Biopharmaceutical Third-Party Logistics Market Report 2025 - Product Image

Biopharmaceutical Third-Party Logistics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cell and Gene Therapy Third-Party Logistics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Cell and Gene Therapy Third-Party Logistics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Healthcare Third party Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Healthcare Third party Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From

About the Biopharmaceutical Third Party Logistics Market

Biopharmaceutical Third Party Logistics (3PL) is a specialized form of logistics services that focuses on the storage, transportation, and distribution of biopharmaceutical products. These products are typically temperature-sensitive and require specialized handling and storage conditions. 3PL providers offer a range of services, including temperature-controlled storage, order fulfillment, and distribution. They also provide value-added services such as inventory management, packaging, and labeling. 3PL providers are an important part of the biopharmaceutical supply chain, as they help ensure that products are delivered safely and on time. They also help reduce costs and improve efficiency by providing a range of services that are tailored to the needs of the biopharmaceutical industry. Some of the leading companies in the biopharmaceutical 3PL market include AmerisourceBergen, Cardinal Health, McKesson, FedEx, UPS, and DHL. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.